Greenco Biologicals Profile
Key Indicators
- Authorised Capital ₹ 3.50 M
as on 26-07-2024
- Paid Up Capital ₹ 3.40 M
as on 26-07-2024
- Company Age 35 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.65 Cr
as on 26-07-2024
- Satisfied Charges ₹ 4.00 Cr
as on 26-07-2024
- Revenue 83.53%
(FY 2023)
- Profit 102.69%
(FY 2023)
- Ebitda 173.99%
(FY 2023)
- Net Worth 1.10%
(FY 2023)
- Total Assets 3.12%
(FY 2023)
About Greenco Biologicals
The Corporate was formerly known as Aarkay Biologicals Private Limited. The Company is engaged in the Metals And Minerals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 M and a paid-up capital of Rs 3.40 M.
The company currently has active open charges totaling ₹2.65 Cr. The company has closed loans amounting to ₹4.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Romita Sinha and Laltu Dhali serve as directors at the Company.
- CIN/LLPIN
U24231WB1989PTC047199
- Company No.
047199
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jul 1989
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Greenco Biologicals Pvt Ltd offer?
Greenco Biologicals Pvt Ltd offers a wide range of products and services, including Hand Sanitizers & Personal Hygiene, Antiseptic Liquid & Cream, Antiparasitic Drug, Albendazole Tablets, Eye Cosmetic, Eye Gel, Common Disease Medicines, Eye Drops, Cough Syrup, Allopathic Cough Syrup.
Who are the key members and board of directors at Greenco Biologicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Romita Sinha  | Director | 01-Aug-2003 | Current |
| Laltu Dhali | Director | 17-Apr-2017 | Current |
Financial Performance of Greenco Biologicals.
Greenco Biologicals Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 83.53% increase. The company also saw a substantial improvement in profitability, with a 102.69% increase in profit. The company's net worth moved up by a moderate rise of 1.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Greenco Biologicals?
In 2023, Greenco Biologicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 19 Jan 2022 | ₹2.65 Cr | Open |
Others Creation Date: 14 Feb 2011 | ₹3.37 Cr | Satisfied |
Punjab National Bank Creation Date: 11 Feb 2010 | ₹4.00 M | Satisfied |
How Many Employees Work at Greenco Biologicals?
Greenco Biologicals has a workforce of 44 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Greenco Biologicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Greenco Biologicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
